{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:07:03Z","timestamp":1783444023531,"version":"3.54.6"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Predicting long-term visual outcomes and axonal loss following acute optic neuritis (ON) is critical for choosing treatment. Predictive models including all clinical and paraclinical measures of optic nerve dysfunction following ON are lacking.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>Using a prospective study method, to identify 1 and 3 months predictors of 6 and 12 months visual outcome (low contrast letter acuity 2.5%) and axonal loss [retinal nerve fiber layer thickness and multifocal evoked potential (mfVEP) amplitude] following acute ON.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In total, 37 patients of acute ON onset were evaluated within 14 days using between-eye asymmetry of visual acuity, color vision (Ishihara plates), optical coherence tomography, mfVEP, and optic nerve magnetic resonance imaging [magnetic transfer ratio (MTR) and diffusion tensor imaging (DTI)].<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Visual outcome at 6 and 12 months was best predicted by Ishihara asymmetry at 1 and 3 months following ON onset. Axonal loss at 6 and 12 months was reliably predicted by Ishihara asymmetry at 1 month. Optic nerve MTR and DTI at 3 months post-acute ON could predict axonal loss at 6 and 12 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Simple Ishihara asymmetry testing 1 month after acute ON onset can best predict visual outcome and axonal loss at 6 and 12 months in a clinical or research setting.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2022.945034","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T06:13:20Z","timestamp":1662617600000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Early predictors of visual and axonal outcomes after acute optic neuritis"],"prefix":"10.3389","volume":"13","author":[{"given":"Minh N. L.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott C.","family":"Kolbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Butzkueven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen B.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Fielding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor J.","family":"Kilpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary F.","family":"Egan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Klistorner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke","family":"van der Walt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/S0161-6420(94)31103-1","article-title":"The course of visual recovery after optic neuritis","volume":"101","author":"Beck","year":"1994","journal-title":"Ophthalmology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/S0161-6420(87)33349-4","article-title":"Deficits in visual function after resolution of optic neuritis","volume":"94","author":"Fleishman","year":"1987","journal-title":"Ophthalmology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1136\/bjo.68.10.756","article-title":"Contrast sensitivity measurements in acute and resolved optic neuritis","volume":"68","author":"Beck","year":"1984","journal-title":"Br J Ophthalmol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1474-4422(16)30377-5","article-title":"Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial","volume":"16","author":"Cadavid","year":"2017","journal-title":"Lancet Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"105741","DOI":"10.1016\/j.clineuro.2020.105741","article-title":"Randomized control trial of evaluation of Clemastine effects on visual evoked potential, nerve fiber layer and ganglion cell layer complex in patients with optic neuritis","volume":"193","author":"Moghaddasi","year":"2020","journal-title":"Clin Neurol Neurosurg."},{"key":"B6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1474-4422(16)00004-1","article-title":"Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial","volume":"15","author":"Raftopoulos","year":"2016","journal-title":"Lancet Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1177\/1352458517742979","article-title":"Amiloride does not protect retinal nerve fibre layer thickness in optic neuritis in a phase 2 randomised controlled trial","volume":"25","author":"McKee","year":"2019","journal-title":"Mult Scler."},{"key":"B8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12883-020-01645-z","article-title":"Fingolimod after a first unilateral episode of acute optic neuritis (MOVING) - preliminary results from a randomized, rater-blind, active-controlled, phase 2 trial","volume":"20","author":"Albert","year":"2020","journal-title":"BMC Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1001\/archopht.1993.01090060061023","article-title":"Optic neuritis treatment trial: one year follow up results","volume":"111","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/j.1468-1331.2007.01736.x","article-title":"Optical coherence tomography in optic neuritis and multiple sclerosis: a review","volume":"14","author":"Kallenbach","year":"2007","journal-title":"Eur J Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/ana.20575","article-title":"Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis","volume":"58","author":"Trip","year":"2005","journal-title":"Ann Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10633-008-9147-4","article-title":"Multifocal VEP and OCT in optic neuritis: a topographical study of the structure-function relationship","volume":"118","author":"Klistorner","year":"2009","journal-title":"Doc Ophthalmol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1212\/NXI.0000000000000135","article-title":"Acute Optic Neuritis","volume":"2","author":"Galetta","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B14","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1001\/jamaneurol.2019.3283","article-title":"Using acute optic neuritis trials to assess neuroprotective and remyelinating therapies in multiple sclerosis","volume":"77","author":"Andorr\u00e0","year":"2020","journal-title":"JAMA Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e52291","DOI":"10.1371\/journal.pone.0052291","article-title":"Optic nerve magnetisation transfer ratio after acute optic neuritis predicts axonal and visual outcomes","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e83825","DOI":"10.1371\/journal.pone.0083825","article-title":"Optic nerve diffusion tensor imaging after acute optic neuritis predicts axonal and visual outcomes","volume":"8","author":"van der Walt","year":"2013","journal-title":"PLoS One."},{"key":"B17","doi-asserted-by":"crossref","DOI":"10.1002\/0470869526","volume-title":"Quantitative MRI of the Brain: Measuring Changes Caused by Disease","author":"Tofts","year":"2003"},{"key":"B18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/ana.20202","article-title":"Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain","volume":"56","author":"Schmierer","year":"2004","journal-title":"Ann Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.neuroimage.2011.02.041","article-title":"Magnetisation transfer ratio in optic neuritis is associated with axonal loss, but not with demyelination","volume":"56","author":"Klistorner","year":"2011","journal-title":"Neuroimage."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.neuroimage.2003.07.005","article-title":"Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia","volume":"2003","author":"Song","year":"2003","journal-title":"Neuroimage"},{"key":"B21","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis:2005 revisions to the \u201cMcDonald Criteria\u201d","volume":"58","author":"Polman","year":"2005","journal-title":"Ann Neurol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1212\/01.WNL.0000094315.19931.90","article-title":"Contrast letter acuity as a visual component for the multiple sclerosis functional composite","volume":"61","author":"Balcer","year":"2003","journal-title":"Neurology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1212\/01.WNL.0000154521.40686.63","article-title":"Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis","volume":"64","author":"Baier","year":"2005","journal-title":"Neurology."},{"key":"B24","article-title":"Multifocal visual evoked potential analysis of inflammatory or demyelinating optic neuritis","volume-title":"Ophthalmology.","author":"Fraser","year":"2006"},{"key":"B25","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.neuroimage.2008.12.047","article-title":"Optic nerve diffusion changes and atrophy jointly predict visual dysfunction after optic neuritis","volume":"45","author":"Kolbe","year":"2009","journal-title":"Neuroimage."},{"key":"B26","first-page":"2278","article-title":"Color vision defect type and spatial vision in the optic neuritis treatment trial","volume":"38","author":"Schneck","year":"1997","journal-title":"IOVS."},{"key":"B27","doi-asserted-by":"publisher","first-page":"5780","DOI":"10.1167\/iovs.15-18736","article-title":"Retinal ganglion cell layer thinning and vision outcome in NAION and optic neuritis over six months","volume":"55","author":"Wang","year":"2014","journal-title":"Invest Ophthalmol Visual Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1444-0938.2004.tb05057.x","article-title":"Clinical colour vision tests","volume":"87","author":"Dain","year":"2004","journal-title":"Clin Exp Optom."},{"key":"B29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1444-0938.2006.00015.x","article-title":"The new Richmond HRR pseudoisochromatic test for colour vision is better than the Ishihara test","volume":"89","author":"Cole","year":"2006","journal-title":"Clin Exp Optom."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/s41433-019-0361-y","article-title":"The effect of reduced contrast sensitivity on colour vision testing","volume":"33","author":"Lipsky","year":"2019","journal-title":"Eye."},{"key":"B31","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1177\/1352458517690822","article-title":"Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis","volume":"23","author":"Balcer","year":"2017","journal-title":"Mult Scler."},{"key":"B32","unstructured":"2018"},{"key":"B33","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/1522-2586(200006)11:6<586::AID-JMRI3>3.0.CO;2-V","article-title":"Magnetization transfer and multicomponent T2 relaxation measurements with histopathologic correlation in an experimental model of MS","volume":"11","author":"Gareau","year":"2000","journal-title":"J Magn Reson Imaging."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1093\/brain\/awl039","article-title":"Selective magnetization transfer ratio decrease in the visual cortex following optic neuritis","volume":"129","author":"Audoin","year":"2006","journal-title":"Brain."},{"key":"B35","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/ana.23573","article-title":"A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis","volume":"72","author":"Suhs","year":"2012","journal-title":"Ann Neurol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1038\/eye.2008.363","article-title":"Comparison of time domain Stratus OCT and spectral domain SLO\/OCT for assessment of macular thickness and volume","volume":"23","author":"Forte","year":"2009","journal-title":"Eye (Lond)."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.ophtha.2011.11.032","article-title":"Ganglion cell loss in relation to visual disability in multiple sclerosis","volume":"119","author":"Walter","year":"2012","journal-title":"Ophthalmology."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.clinph.2014.11.010","article-title":"Multifocal VEP assessment of optic neuritis evolution","volume":"126","author":"Alshowaeir","year":"2015","journal-title":"Clin Neurophysiol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.945034\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T06:13:25Z","timestamp":1662617605000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.945034\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,8]]},"references-count":38,"alternative-id":["10.3389\/fneur.2022.945034"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.945034","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,8]]},"article-number":"945034"}}